<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> (T2DM) is characterized by progressive β-cell dysfunctioning and <z:hpo ids='HP_0000855'>insulin resistance</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>This article reviews recent literature with special focus on inflammatory mechanisms that provoke the pathogenesis of T2DM </plain></SENT>
<SENT sid="2" pm="."><plain>We have focused on the recent advances in progression of T2DM including various inflammatory mechanisms that might induce <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:hpo ids='HP_0000855'>insulin resistance</z:hpo>, decrease insulin secretion from pancreatic islets and dysfunctioning of β-cells </plain></SENT>
<SENT sid="3" pm="."><plain>Here we have also summarized the role of various pro-<z:mp ids='MP_0002501'>inflammatory mediators</z:mp> involved in inflammatory mechanisms which may further alter the <z:mpath ids='MPATH_458'>normal</z:mpath> structure of β-cells by inducing pancreatic islet's <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="4" pm="."><plain>In conclusion, it is suggested that the role of <z:mp ids='MP_0001845'>inflammation</z:mp> in pathogenesis of T2DM is crucial and cannot be neglected </plain></SENT>
<SENT sid="5" pm="."><plain>Moreover, the insight of <z:mp ids='MP_0001845'>inflammatory responses</z:mp> in T2DM may provide a new gateway for the better treatment of <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>J </plain></SENT>
<SENT sid="7" pm="."><plain>Cell </plain></SENT>
<SENT sid="8" pm="."><plain>Biochem. © 2012 Wiley Periodicals, Inc </plain></SENT>
</text></document>